Panton–Valentine leukocidin (PVL), a pore-forming cytotoxic secreted toxin, has been
associated with severe Staphylococcus aureus pneumonia and prototypical skin lesions …

A subset of patients has long-lasting symptoms after mild to moderate Coronavirus disease
2019 (COVID-19). In a prospective observational cohort study, we analyze clinical and …

Introduction Common variable immunodeficiency related interstitial lung disease (CVID-ILD,
also referred to as GLILD) is generally considered a manifestation of systemic immune …

Infection-triggered disease onset, chronic immune activation and autonomic dysregulation in
CFS point to an autoimmune disease directed against neurotransmitter receptors …

Background Inborn errors of immunity (IEI) are rare diseases, which makes diagnosis a
challenge. A better description of the initial presenting manifestations should improve …

Introduction Interstitial lung disease (ILD) is a frequent manifestation of systemic sclerosis
(SSc), and cytokines can contribute to the disease pathology. The aim of the current study …

Introduction: The German PID-NET registry was founded in 2009, serving as the first national
registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the …

Background Panton-Valentine leukocidin (PVL)–producing Staphylococcus aureus (PVL-
SA) strains are frequently associated with large, recurring abscesses in otherwise healthy …

Clinical trials on the use of COVID-19 convalescent plasma remain inconclusive. While data
on safety is increasingly available, evidence for efficacy is still sparse. Subgroup analyses …

Epstein-Barr virus (EBV) has long been discussed as a possible cause or trigger of Chronic
Fatigue Syndrome (CFS). In a subset of patients the disease starts with infectious …